Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

340B For All? Rx Discount Expansion Coming -- With Or Without Health Reform

Executive Summary

The pharmaceutical industry should prepare for an expansion of the 340B drug discount program in the U.S. - regardless of the outcome of the health care reform debate

You may also be interested in...



340B Expansion, Revisions Becoming Front-Burner Issues For Pharma

Moves to expand and revise the federal 340B drug discount program as part of broad health care reform legislation are becoming high-profile concerns in the pharmaceutical industry

340B Expansion, Revisions Becoming Front-Burner Issues For Pharma

Moves to expand and revise the federal 340B drug discount program as part of broad health care reform legislation are becoming high-profile concerns in the pharmaceutical industry

New Zealand's PHARMAC Gains $41 Million In Funding; Adds Sprycel And Humira For Reimbursement

PERTH, Australia - New Zealand's Pharmaceutical Management Agency's 2009/2010 budget saw a $41 million increase, bringing the total agency budget to $694 million, with $10 million of the new funds transferred from New Zealand District Health Board budgets

Related Content

Topics

UsernamePublicRestriction

Register

OM013658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel